Abstract
BackgroundIncreasing evidence suggests that therapeutic drug monitoring is useful in rheumatological patients receiving anti-TNF therapy. By measuring anti-drug antibodies (ADA) and serum drug levels the therapy may be optimized.ObjectivesTo investigate...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
